{"id":"NCT02305381","sponsor":"Novo Nordisk A/S","briefTitle":"Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes","officialTitle":"Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-12-01","primaryCompletion":"2015-11-21","completion":"2015-11-21","firstPosted":"2014-12-02","resultsPosted":"2018-02-19","lastUpdate":"2019-06-11"},"enrollment":397,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"semaglutide","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Semaglutide 0.5 mg/Week","type":"EXPERIMENTAL"},{"label":"Semaglutide 1.0 mg/Week","type":"EXPERIMENTAL"},{"label":"Semaglutide Placebo 0.5 mg/Week","type":"PLACEBO_COMPARATOR"},{"label":"Semaglutide Placebo 1.0 mg/Week","type":"PLACEBO_COMPARATOR"}],"summary":"This trial is conducted in Asia, Europe and the United States of America (USA). The aim of the trial is to investigate efficacy and safety of semaglutide once weekly versus placebo as add-on to basal insulin alone or basal insulin in combination with metformin in subjects with type 2 diabetes.","primaryOutcome":{"measure":"Change in HbA1c (Glycosylated Haemoglobin)","timeFrame":"Week 0, week 30","effectByArm":[{"arm":"Semaglutide 0.5 mg","deltaMin":-1.45,"sd":0.09},{"arm":"Semaglutide 1.0 mg","deltaMin":-1.85,"sd":0.09},{"arm":"Placebo","deltaMin":-0.09,"sd":0.09}],"pValues":[{"comp":"OG001 vs OG002","p":"< 0.0001"},{"comp":"OG000 vs OG002","p":"< 0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":99,"countries":["United States","Germany","Japan","Puerto Rico","Serbia","Slovakia"]},"refs":{"pmids":["30865526","29688502","29687620","29766634","29862621","30615985","32998732","31903692","31769496","31215727"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":132},"commonTop":["Nausea","Nasopharyngitis","Vomiting","Lipase increased","Diarrhoea"]}}